Cabaletta Bio, Inc. (CABA)
USD 1.11
(-6.72%)
USD 1.11
(-6.72%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -188.22 Million USD | -146.14% |
| 2022 | -76.46 Million USD | 37.43% |
| 2021 | -122.22 Million USD | -20.5% |
| 2020 | -101.42 Million USD | 25.53% |
| 2019 | -136.2 Million USD | -1349.12% |
| 2018 | 10.9 Million USD | 1090500.0% |
| 2017 | -1000.00 USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -167.12 Million USD | 11.21% |
| 2024 Q2 | -171.21 Million USD | -2.45% |
| 2023 Q2 | -123.87 Million USD | -38.92% |
| 2023 FY | -188.22 Million USD | -146.14% |
| 2023 Q3 | -111.23 Million USD | 10.21% |
| 2023 Q1 | -89.17 Million USD | -16.61% |
| 2023 Q4 | -188.22 Million USD | -69.22% |
| 2022 Q4 | -76.46 Million USD | -25.02% |
| 2022 Q3 | -61.16 Million USD | -29.67% |
| 2022 Q2 | -47.16 Million USD | 20.79% |
| 2022 Q1 | -59.55 Million USD | 51.27% |
| 2022 FY | -76.46 Million USD | 37.43% |
| 2021 Q4 | -122.22 Million USD | -3.35% |
| 2021 Q3 | -118.26 Million USD | -18.86% |
| 2021 FY | -122.22 Million USD | -20.5% |
| 2021 Q1 | -97.27 Million USD | 4.09% |
| 2021 Q2 | -99.49 Million USD | -2.28% |
| 2020 Q4 | -101.42 Million USD | 6.67% |
| 2020 Q2 | -112.09 Million USD | 14.43% |
| 2020 Q1 | -131 Million USD | 3.82% |
| 2020 FY | -101.42 Million USD | 25.53% |
| 2020 Q3 | -108.67 Million USD | 3.05% |
| 2019 Q2 | -75.25 Million USD | -327.94% |
| 2019 Q4 | -136.2 Million USD | -91.73% |
| 2019 Q3 | -71.04 Million USD | 5.6% |
| 2019 Q1 | 33.01 Million USD | 200.0% |
| 2019 FY | -136.2 Million USD | -1349.12% |
| 2018 Q1 | 1000.00 USD | 0.0% |
| 2018 Q4 | -33.01 Million USD | 0.0% |
| 2018 FY | 10.9 Million USD | 1090500.0% |
| 2017 FY | -1000.00 USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AbCellera Biologics Inc. | -55.94 Million USD | -236.468% |
| Alkermes plc | -166.73 Million USD | -12.883% |
| Agenus Inc. | 274.13 Million USD | 168.659% |
| Alnylam Pharmaceuticals, Inc. | 1.86 Billion USD | 110.066% |
| Aptorum Group Limited | 1.35 Million USD | 13969.832% |
| Ardelyx, Inc. | 34.51 Million USD | 645.376% |
| Arrowhead Pharmaceuticals, Inc. | 4.28 Million USD | 4497.664% |
| Bicycle Therapeutics plc | -481.46 Million USD | 60.907% |
| BioXcel Therapeutics, Inc. | 36.16 Million USD | 620.477% |
| ChromaDex Corporation | -24.04 Million USD | -682.685% |
| Chimerix, Inc. | -25.51 Million USD | -637.626% |
| Corbus Pharmaceuticals Holdings, Inc. | 6.96 Million USD | 2801.176% |
| Caribou Biosciences, Inc. | -23.67 Million USD | -694.949% |
| CRISPR Therapeutics AG | -150.84 Million USD | -24.777% |
| Precision BioSciences, Inc. | -85.41 Million USD | -120.372% |
| Dyadic International, Inc. | -6.37 Million USD | -2851.036% |
| Eton Pharmaceuticals, Inc. | -15.93 Million USD | -1081.322% |
| Fortress Biotech, Inc. | 7.66 Million USD | 2555.577% |
| Lantern Pharma Inc. | -21.7 Million USD | -767.242% |
| HOOKIPA Pharma Inc. | -110.53 Million USD | -70.278% |
| Inhibikase Therapeutics, Inc. | -8.54 Million USD | -2103.162% |
| Incyte Corporation | -3.17 Billion USD | 94.072% |
| IO Biotech, Inc. | -140.69 Million USD | -33.775% |
| Jaguar Health, Inc. | 29.39 Million USD | 740.4% |
| Novavax, Inc. | -298.29 Million USD | 36.901% |
| Janux Therapeutics, Inc. | 5.33 Million USD | 3626.7% |
| Opthea Limited | 28.15 Million USD | 768.456% |
| Ligand Pharmaceuticals Incorporated | -16.78 Million USD | -1021.091% |
| ContextLogic Inc. | -232 Million USD | 18.871% |
| MiMedx Group, Inc. | -33.9 Million USD | -455.205% |
| Pyxis Oncology, Inc. | 10.19 Million USD | 1946.199% |
| TransCode Therapeutics, Inc. | -2.31 Million USD | -8023.341% |
| NextCure, Inc. | -6.47 Million USD | -2805.975% |
| Ocuphire Pharma, Inc. | -50.5 Million USD | -272.705% |
| Oncternal Therapeutics, Inc. | -6.37 Million USD | -2850.619% |
| Outlook Therapeutics, Inc. | 12.16 Million USD | 1647.446% |
| Vaxcyte, Inc. | -368.22 Million USD | 48.885% |
| PDS Biotechnology Corporation | -32.7 Million USD | -475.44% |
| Madrigal Pharmaceuticals, Inc. | 17.27 Million USD | 1189.362% |
| Pharming Group N.V. | 109.8 Million USD | 271.415% |
| Pieris Pharmaceuticals, Inc. | -17.39 Million USD | -981.973% |
| Avidity Biosciences, Inc. | -175.23 Million USD | -7.413% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -916.315% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -916.315% |
| Sangamo Therapeutics, Inc. | -7.1 Million USD | -2550.986% |
| Sol-Gel Technologies Ltd. | -5.86 Million USD | -3111.945% |
| Acelyrin, Inc. | -216.9 Million USD | 13.224% |
| Salarius Pharmaceuticals, Inc. | -5.61 Million USD | -3254.921% |
| SELLAS Life Sciences Group, Inc. | -1.72 Million USD | -10817.633% |
| Summit Therapeutics Inc. | 34.67 Million USD | 642.827% |
| Sensei Biotherapeutics, Inc. | -6.8 Million USD | -2666.721% |
| Senti Biosciences, Inc. | 1.74 Million USD | 10917.241% |
| Stoke Therapeutics, Inc. | -184.6 Million USD | -1.957% |
| Syros Pharmaceuticals, Inc. | -77.45 Million USD | -143.018% |
| Alaunos Therapeutics, Inc. | -6.06 Million USD | -3004.916% |
| Telomir Pharmaceuticals, Inc. Common Stock | 99.76 Thousand USD | 188755.795% |
| Entrada Therapeutics, Inc. | 628 Thousand USD | 30071.338% |
| VistaGen Therapeutics, Inc. | -117.04 Million USD | -60.809% |
| Wave Life Sciences Ltd. | -168.23 Million USD | -11.881% |
| Sorrento Therapeutics, Inc. | 110.87 Million USD | 269.766% |
| TRACON Pharmaceuticals, Inc. | -7.59 Million USD | -2377.883% |
| Barinthus Biotherapeutics plc | -129.11 Million USD | -45.778% |
| Psyence Biomedical Ltd. | 6.89 Million USD | 2829.963% |
| Phathom Pharmaceuticals, Inc. | -242.36 Million USD | 22.34% |
| Immix Biopharma, Inc. | -17.5 Million USD | -974.941% |
| Keros Therapeutics, Inc. | -316.7 Million USD | 40.569% |
| MEI Pharma, Inc. | -3.7 Million USD | -4980.162% |
| Windtree Therapeutics, Inc. | 12.51 Million USD | 1604.436% |
| Xeris Biopharma Holdings, Inc. | 161.74 Million USD | 216.371% |
| Rigel Pharmaceuticals, Inc. | 27.79 Million USD | 777.221% |
| Fortress Biotech, Inc. | 7.66 Million USD | 2555.577% |
| Precigen, Inc. | -481 Thousand USD | -39030.977% |
| Clearside Biomedical, Inc. | 14.08 Million USD | 1436.695% |
| AlloVir, Inc. | -62.69 Million USD | -200.23% |
| C4 Therapeutics, Inc. | -55.61 Million USD | -238.44% |
| Fate Therapeutics, Inc. | 61.66 Million USD | 405.225% |
| ImmuCell Corporation | 10.99 Million USD | 1812.56% |
| IDEAYA Biosciences, Inc. | -154.14 Million USD | -22.105% |
| Onconetix, Inc. | 5.33 Million USD | 3630.38% |
| PureTech Health plc | -167.19 Million USD | -12.574% |
| VYNE Therapeutics Inc. | -30.46 Million USD | -517.925% |
| Elevation Oncology, Inc. | -19.11 Million USD | -884.517% |
| Kintara Therapeutics, Inc. | -4.9 Million USD | -3734.182% |
| Seer, Inc. | -4.24 Million USD | -4339.151% |
| Verrica Pharmaceuticals Inc. | -24.03 Million USD | -683.043% |
| Innoviva, Inc. | 255.56 Million USD | 173.649% |
| Aadi Bioscience, Inc. | -55.86 Million USD | -236.925% |
| ESSA Pharma Inc. | -33.62 Million USD | -459.819% |
| GlycoMimetics, Inc. | -40.98 Million USD | -359.248% |
| GT Biopharma, Inc. | -1.02 Million USD | -18334.868% |
| Inhibrx Biosciences, Inc. | -67.78 Million USD | -177.68% |
| Akebia Therapeutics, Inc. | 61.25 Million USD | 407.263% |
| Catalyst Pharmaceuticals, Inc. | -134.07 Million USD | -40.38% |
| Longboard Pharmaceuticals, Inc. | -13.85 Million USD | -1258.401% |
| Orchestra BioMed Holdings, Inc. | -28.87 Million USD | -551.912% |
| Alzamend Neuro, Inc. | -75.33 Thousand USD | -249747.346% |
| Rocket Pharmaceuticals, Inc. | -30.86 Million USD | -509.876% |
| Aptose Biosciences Inc. | -8.19 Million USD | -2196.806% |
| ZyVersa Therapeutics, Inc. | -3.12 Million USD | -5915.306% |
| Soligenix, Inc. | -4.95 Million USD | -3701.198% |
| Century Therapeutics, Inc. | 847 Thousand USD | 22321.96% |
| Kura Oncology, Inc. | -20.11 Million USD | -835.58% |
| TScan Therapeutics, Inc. | -40.92 Million USD | -359.903% |
| Intensity Therapeutics, Inc. | -8.39 Million USD | -2141.248% |
| Ocean Biomedical, Inc. | 1.82 Million USD | 10432.136% |
| CytomX Therapeutics, Inc. | -3.19 Million USD | -5787.394% |
| Autolus Therapeutics plc | -186.59 Million USD | -0.869% |
| Mineralys Therapeutics, Inc. | -49.3 Million USD | -281.754% |
| EyePoint Pharmaceuticals, Inc. | -275.79 Million USD | 31.753% |
| Eterna Therapeutics Inc. | 34.26 Million USD | 649.259% |
| Adaptive Biotechnologies Corporation | 164.36 Million USD | 214.511% |
| GRI Bio, Inc. | -1.79 Million USD | -10391.639% |
| Xenetic Biosciences, Inc. | -8.98 Million USD | -1995.28% |
| Tenaya Therapeutics, Inc. | -33.25 Million USD | -465.956% |
| IGM Biosciences, Inc. | -72.6 Million USD | -159.235% |
| INmune Bio, Inc. | -25.41 Million USD | -640.703% |
| Heron Therapeutics, Inc. | 150.95 Million USD | 224.689% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -271.543% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -1058.322% |
| Entero Therapeutics, Inc. | -2.88 Million USD | -6424.257% |
| Milestone Pharmaceuticals Inc. | 38.01 Million USD | 595.12% |
| X4 Pharmaceuticals, Inc. | -41.18 Million USD | -357.011% |
| Atara Biotherapeutics, Inc. | 31.88 Million USD | 690.309% |
| Coherus BioSciences, Inc. | 377.95 Million USD | 149.8% |
| Verastem, Inc. | -37.27 Million USD | -404.909% |
| Abeona Therapeutics Inc. | -9.07 Million USD | -1974.507% |
| Pliant Therapeutics, Inc. | -51.86 Million USD | -262.925% |
| Tonix Pharmaceuticals Holding Corp. | -15.13 Million USD | -1143.608% |
| Histogen Inc. | -7.48 Million USD | -2413.958% |
| Aprea Therapeutics, Inc. | -21.6 Million USD | -771.114% |
| Surrozen, Inc. | -32.66 Million USD | -476.231% |
| Organovo Holdings, Inc. | -1.5 Million USD | -12389.715% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -4377.71% |
| Ovid Therapeutics Inc. | 18.96 Million USD | 1092.711% |
| Panbela Therapeutics, Inc. | 2.61 Million USD | 7294.954% |
| CASI Pharmaceuticals, Inc. | 4.15 Million USD | 4628.874% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.38 Million USD | -2145.754% |
| Centessa Pharmaceuticals plc | -43.44 Million USD | -333.267% |
| Hepion Pharmaceuticals, Inc. | -14.57 Million USD | -1191.225% |
| Arcturus Therapeutics Holdings Inc. | -316.78 Million USD | 40.585% |
| BioRestorative Therapies, Inc. | -722.06 Thousand USD | -25967.086% |
| Apollomics, Inc. | -27.39 Million USD | -587.06% |
| Amarin Corporation plc | -191.04 Million USD | 1.476% |
| Mesoblast Limited | 55.96 Million USD | 436.329% |
| Turnstone Biologics Corp. | -14.58 Million USD | -1190.592% |
| Kymera Therapeutics, Inc. | -25.29 Million USD | -644.188% |
| Synaptogenix, Inc. | -28.66 Million USD | -556.7% |
| Tiziana Life Sciences Ltd | -936 Thousand USD | -20008.974% |
| Aurinia Pharmaceuticals Inc. | 48.73 Million USD | 486.235% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -21733.013% |
| Monopar Therapeutics Inc. | -7.26 Million USD | -2490.393% |
| Exelixis, Inc. | -73.05 Million USD | -157.659% |
| Better Therapeutics, Inc. | -860 Thousand USD | -21786.047% |
| Nurix Therapeutics, Inc. | -24.01 Million USD | -683.825% |
| Apellis Pharmaceuticals, Inc. | -241.37 Million USD | 22.02% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 25671.077% |
| Dermata Therapeutics, Inc. | -7.43 Million USD | -2430.473% |
| Aridis Pharmaceuticals, Inc. | 1.25 Million USD | 15109.569% |
| Gritstone bio, Inc. | 39.49 Million USD | 576.627% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -123.802% |
| TNF Pharmaceuticals, Inc. | -2.63 Million USD | -7050.835% |
| Avid Bioservices, Inc. | 169.72 Million USD | 210.895% |
| Insmed Incorporated | 721.62 Million USD | 126.083% |
| Virpax Pharmaceuticals, Inc. | -9.14 Million USD | -1958.959% |
| MediWound Ltd. | -5.32 Million USD | -3436.64% |
| OmniAb, Inc. | 9.2 Million USD | 2145.203% |
| Alector, Inc. | -35.63 Million USD | -428.159% |
| Seres Therapeutics, Inc. | 85.97 Million USD | 318.934% |
| Checkpoint Therapeutics, Inc. | -4.92 Million USD | -3719.399% |
| Viracta Therapeutics, Inc. | 13.23 Million USD | 1521.709% |
| Zai Lab Limited | -775 Million USD | 75.714% |
| Revance Therapeutics, Inc. | 340.55 Million USD | 155.269% |
| Aura Biosciences, Inc. | -21.52 Million USD | -774.425% |
| Lyell Immunopharma, Inc. | -82.48 Million USD | -128.201% |
| Immunic, Inc. | -45.34 Million USD | -315.13% |
| Tarsus Pharmaceuticals, Inc. | -193.21 Million USD | 2.585% |
| Veracyte, Inc. | -203.82 Million USD | 7.656% |
| InMed Pharmaceuticals Inc. | 638.29 Million USD | 129.488% |
| FibroGen, Inc. | 56.76 Million USD | 431.566% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 2213.644% |
| Adial Pharmaceuticals, Inc. | -2.82 Million USD | -6557.748% |
| Sonnet BioTherapeutics Holdings, Inc. | -2.07 Million USD | -8991.225% |
| Jazz Pharmaceuticals plc | 4.59 Billion USD | 104.1% |
| Cyclacel Pharmaceuticals, Inc. | -3.34 Million USD | -5533.643% |
| Amylyx Pharmaceuticals, Inc. | -165.96 Million USD | -13.41% |
| TG Therapeutics, Inc. | 17.86 Million USD | 1153.745% |
| Galecto, Inc. | -21.21 Million USD | -787.161% |
| Calithera Biosciences, Inc. | -23.78 Million USD | -691.339% |
| Fortrea Holdings Inc. | 1.56 Billion USD | 111.993% |
| KalVista Pharmaceuticals, Inc. | -24.47 Million USD | -669.124% |
| Aptevo Therapeutics Inc. | -11.5 Million USD | -1535.7% |
| XBiotech Inc. | -200.02 Million USD | 5.901% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -123.802% |
| Lyra Therapeutics, Inc. | 4.52 Million USD | 4256.802% |
| Foghorn Therapeutics Inc. | -35.26 Million USD | -433.761% |
| Y-mAbs Therapeutics, Inc. | -77.21 Million USD | -143.751% |
| Theravance Biopharma, Inc. | 5.69 Million USD | 3407.327% |
| Ultragenyx Pharmaceutical Inc. | -170.41 Million USD | -10.448% |
| Metagenomi, Inc. Common Stock | -92.37 Million USD | -103.759% |
| Vaxxinity, Inc. | 10.13 Million USD | 1957.679% |
| BioCryst Pharmaceuticals, Inc. | 736.26 Million USD | 125.564% |
| Gain Therapeutics, Inc. | -10.76 Million USD | -1648.03% |
| Cartesian Therapeutics, Inc. | -65.95 Million USD | -185.372% |
| NexImmune, Inc. | -3.13 Million USD | -5906.428% |
| Creative Medical Technology Holdings, Inc. | -3.45 Million USD | -5351.429% |
| Marker Therapeutics, Inc. | -15.11 Million USD | -1145.546% |
| Regeneron Pharmaceuticals, Inc. | -27.1 Million USD | -594.539% |
| Chemomab Therapeutics Ltd. | -8.97 Million USD | -1996.913% |
| Scopus BioPharma Inc. | -124.57 Thousand USD | -150989.705% |
| RAPT Therapeutics, Inc. | -40.57 Million USD | -363.916% |
| Ainos, Inc. | 4.07 Million USD | 4715.579% |
| Pluri Inc. | 22.82 Million USD | 924.478% |
| Prothena Corporation plc | -608.34 Million USD | 69.06% |
| Adaptimmune Therapeutics plc | -118.75 Million USD | -58.493% |
| Celularity Inc. | 65.19 Million USD | 388.725% |
| Rallybio Corporation | -24.1 Million USD | -680.931% |
| Cue Biopharma, Inc. | -33.81 Million USD | -456.551% |
| MeiraGTx Holdings plc | -40.3 Million USD | -367.024% |
| Omeros Corporation | 331.17 Million USD | 156.834% |
| Humacyte, Inc. | -22.48 Million USD | -737.054% |
| Immunocore Holdings plc | -358.59 Million USD | 47.512% |
| Cocrystal Pharma, Inc. | -24.57 Million USD | -665.9% |
| Cidara Therapeutics, Inc. | -30.9 Million USD | -509.107% |
| Blueprint Medicines Corporation | 702.83 Million USD | 126.78% |
| CalciMedica, Inc. | -5.53 Million USD | -3303.617% |
| Marinus Pharmaceuticals, Inc. | -10.21 Million USD | -1742.765% |
| Scholar Rock Holding Corporation | -40.03 Million USD | -370.115% |
| Sana Biotechnology, Inc. | -33.25 Million USD | -466.024% |
| Pulmatrix, Inc. | -10.41 Million USD | -1706.854% |
| Elicio Therapeutics, Inc. | -5.97 Million USD | -3049.071% |
| Vigil Neuroscience, Inc. | -38.14 Million USD | -393.472% |
| Intellia Therapeutics, Inc. | -111.4 Million USD | -68.956% |
| Adlai Nortye Ltd. American Depositary Shares | -59.94 Million USD | -213.993% |
| Cytokinetics, Incorporated | 642.37 Million USD | 129.301% |
| Eloxx Pharmaceuticals, Inc. | -5.82 Million USD | -3132.354% |
| Nutriband Inc. | -251.65 Thousand USD | -74692.277% |
| Protara Therapeutics, Inc. | -34.11 Million USD | -451.657% |
| Vor Biopharma Inc. | 4.3 Million USD | 4477.209% |
| Roivant Sciences Ltd. | -6.03 Billion USD | 96.882% |
| Evogene Ltd. | -19.63 Million USD | -858.643% |
| ProKidney Corp. | -56.23 Million USD | -234.697% |
| Applied Therapeutics, Inc. | -48.67 Million USD | -286.711% |
| Hoth Therapeutics, Inc. | -9.23 Million USD | -1937.633% |
| BridgeBio Pharma, Inc. | 1.36 Billion USD | 113.8% |
| CorMedix Inc. | -43.05 Million USD | -337.187% |
| BioLineRx Ltd. | 7.33 Million USD | 2665.703% |
| Tango Therapeutics, Inc. | -27.46 Million USD | -585.309% |
| Galectin Therapeutics Inc. | 46.14 Million USD | 507.871% |
| Atai Life Sciences N.V. | -28.55 Million USD | -559.08% |
| Renovaro Biosciences Inc. | 2.23 Million USD | 8538.357% |
| Aerovate Therapeutics, Inc. | -22.81 Million USD | -724.947% |
| Zentalis Pharmaceuticals, Inc. | 17.73 Million USD | 1161.291% |
| Sagimet Biosciences Inc. | -75.07 Million USD | -150.713% |
| MediciNova, Inc. | -50.78 Million USD | -270.632% |
| Praxis Precision Medicines, Inc. | -78.8 Million USD | -138.843% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -836619.271% |
| GeoVax Labs, Inc. | -6.45 Million USD | -2816.969% |
| Axsome Therapeutics, Inc. | -199.82 Million USD | 5.806% |
| Biomea Fusion, Inc. | -166.57 Million USD | -12.998% |
| PTC Therapeutics, Inc. | -178.97 Million USD | -5.166% |
| Mereo BioPharma Group plc | -51.46 Million USD | -265.696% |
| Cullinan Oncology, Inc. | -94.84 Million USD | -98.452% |
| Syndax Pharmaceuticals, Inc. | -293.75 Million USD | 35.927% |
| Absci Corporation | -72.59 Million USD | -159.263% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 4222.208% |
| 4D Molecular Therapeutics, Inc. | -234.43 Million USD | 19.714% |
| Dyne Therapeutics, Inc. | -94.21 Million USD | -99.786% |
| Kiniksa Pharmaceuticals, Ltd. | -95.69 Million USD | -96.685% |
| Ventyx Biosciences, Inc. | -39.07 Million USD | -381.714% |
| Allakos Inc. | -24.97 Million USD | -653.634% |
| Imunon, Inc. | -4.21 Million USD | -4366.697% |
| Fulcrum Therapeutics, Inc. | -14.74 Million USD | -1176.76% |
| Corcept Therapeutics Incorporated | -135.4 Million USD | -39.01% |
| BioAtla, Inc. | -109.01 Million USD | -72.661% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 25671.077% |
| Bio-Path Holdings, Inc. | -939 Thousand USD | -19944.728% |
| Allogene Therapeutics, Inc. | 11.96 Million USD | 1672.957% |
| Larimar Therapeutics, Inc. | -21.2 Million USD | -787.705% |
| XOMA Corporation | -29 Million USD | -549.034% |
| Kezar Life Sciences, Inc. | -16.56 Million USD | -1036.594% |
| Cara Therapeutics, Inc. | -9.01 Million USD | -1987.622% |
| aTyr Pharma, Inc. | -7.44 Million USD | -2426.782% |
| Aligos Therapeutics, Inc. | -124.63 Million USD | -51.016% |
| Akero Therapeutics, Inc. | -208.16 Million USD | 9.581% |
| Viridian Therapeutics, Inc. | -81.77 Million USD | -130.157% |
| Eliem Therapeutics, Inc. | -92.76 Million USD | -102.904% |
| EyeGate Pharmaceuticals, Inc. | -859.18 Thousand USD | -21806.833% |
| Akari Therapeutics, Plc | -3.84 Million USD | -4795.189% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 11697.829% |
| Halozyme Therapeutics, Inc. | 1.38 Billion USD | 113.63% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -15741.634% |
| UroGen Pharma Ltd. | 4.39 Million USD | 4386.495% |
| Sutro Biopharma, Inc. | 113.48 Million USD | 265.86% |
| ZIVO Bioscience, Inc. | 71.96 Thousand USD | 261654.709% |
| Orgenesis Inc. | 21.78 Million USD | 964.029% |
| Entera Bio Ltd. | -10.62 Million USD | -1670.816% |
| GH Research PLC | -78.07 Million USD | -141.07% |
| Lisata Therapeutics, Inc. | -22.28 Million USD | -744.49% |
| Reneo Pharmaceuticals, Inc. | -26.65 Million USD | -606.028% |
| Xencor, Inc. | 29.64 Million USD | 734.935% |
| 60 Degrees Pharmaceuticals, Inc. | -1.96 Million USD | -9455.227% |
| Replimune Group, Inc. | 1.41 Million USD | 13430.028% |
| Coeptis Therapeutics Holdings, Inc. | -244.9 Thousand USD | -76753.349% |
| Vanda Pharmaceuticals Inc. | -126.41 Million USD | -48.888% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -15741.634% |
| Portage Biotech Inc. | -4.98 Million USD | -3678.759% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -836619.271% |
| Olema Pharmaceuticals, Inc. | -66.12 Million USD | -184.656% |
| OncoCyte Corporation | -6.56 Million USD | -2767.896% |
| Qualigen Therapeutics, Inc. | 897.41 Thousand USD | 21073.621% |
| Processa Pharmaceuticals, Inc. | -4.55 Million USD | -4031.579% |
| Purple Biotech Ltd. | -14.13 Million USD | -1231.306% |
| CollPlant Biotechnologies Ltd. | -23.75 Million USD | -692.305% |
| scPharmaceuticals Inc. | -6.54 Million USD | -2775.783% |
| ProMIS Neurosciences, Inc. | -16.69 Million USD | -1027.595% |
| HilleVax, Inc. | -165.48 Million USD | -13.738% |
| NeuroSense Therapeutics Ltd. | -2.53 Million USD | -7316.076% |
| Tharimmune, Inc. | -10.93 Million USD | -1621.207% |
| Genprex, Inc. | -6.73 Million USD | -2693.564% |
| Neumora Therapeutics, Inc. Common Stock | -368.8 Million USD | 48.965% |
| Atossa Therapeutics, Inc. | -88.46 Million USD | -112.774% |
| XTL Biopharmaceuticals Ltd. | -1.4 Million USD | -13334.69% |
| Virios Therapeutics, Inc. | -3.31 Million USD | -5574.497% |
| OKYO Pharma Limited | -826.84 Thousand USD | -22663.555% |
| Savara Inc. | 153 Thousand USD | 123119.608% |
| Curis, Inc. | -23.88 Million USD | -687.96% |
| Daré Bioscience, Inc. | -5.15 Million USD | -3549.152% |
| Carmell Therapeutics Corporation | -776.01 Thousand USD | -24154.78% |
| Titan Pharmaceuticals, Inc. | -6.2 Million USD | -2931.894% |
| Achieve Life Sciences, Inc. | 1.18 Million USD | 15983.544% |
| BeiGene, Ltd. | -2.25 Billion USD | 91.646% |
| Kiromic BioPharma, Inc. | 12.33 Million USD | 1625.469% |
| Revolution Medicines, Inc. Warrant | -608.2 Million USD | 69.053% |
| Protagonist Therapeutics, Inc. | -185.58 Million USD | -1.419% |
| Erasca, Inc. | -37.21 Million USD | -405.75% |
| bluebird bio, Inc. | 108.57 Million USD | 273.361% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -14514.568% |
| BioMarin Pharmaceutical Inc. | 378.74 Million USD | 149.695% |
| DBV Technologies S.A. | -126.98 Million USD | -48.221% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -14514.568% |
| Moderna, Inc. | -2.9 Billion USD | 93.525% |
| Vincerx Pharma, Inc. | -10.35 Million USD | -1718.199% |
| Fresh Tracks Therapeutics, Inc. | -10.86 Million USD | -1631.873% |
| Molecular Templates, Inc. | 707 Thousand USD | 26722.348% |
| Acrivon Therapeutics, Inc. Common Stock | -31.37 Million USD | -499.981% |
| Travere Therapeutics, Inc. | 346.6 Million USD | 154.303% |
| Monte Rosa Therapeutics, Inc. | -82.06 Million USD | -129.363% |
| Spruce Biosciences, Inc. | -91.73 Million USD | -105.189% |
| Celldex Therapeutics, Inc. | -32.27 Million USD | -483.23% |
| Cogent Biosciences, Inc. | -34.37 Million USD | -447.533% |
| MacroGenics, Inc. | -66.98 Million USD | -180.988% |
| RenovoRx, Inc. | -1.17 Million USD | -15946.036% |
| Adicet Bio, Inc. | -138.78 Million USD | -35.618% |
| Prime Medicine, Inc. | -27.94 Million USD | -573.634% |
| Aditxt, Inc. | 18.12 Million USD | 1138.691% |
| Adagene Inc. | -87.62 Million USD | -114.796% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -4418.623% |
| Quantum-Si incorporated | -118.55 Million USD | -58.759% |
| Maravai LifeSciences Holdings, Inc. | 36 Million USD | 622.761% |
| Acurx Pharmaceuticals, Inc. | -7.47 Million USD | -2418.267% |
| Voyager Therapeutics, Inc. | -48.5 Million USD | -288.01% |
| SciSparc Ltd. | -2.06 Million USD | -9014.77% |
| Vericel Corporation | 1.27 Million USD | 14839.233% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -1469.585% |
| Minerva Neurosciences, Inc. | 41 Million USD | 559.026% |
| Generation Bio Co. | 31.44 Million USD | 698.512% |
| Astria Therapeutics, Inc. | -175.36 Million USD | -7.331% |
| Black Diamond Therapeutics, Inc. | -30.92 Million USD | -508.673% |
| Arcutis Biotherapeutics, Inc. | 116.59 Million USD | 261.433% |
| Invivyd, Inc. | -198.47 Million USD | 5.167% |
| Relay Therapeutics, Inc. | -90.27 Million USD | -108.508% |
| Quoin Pharmaceuticals, Ltd. | -2.39 Million USD | -7750.061% |
| Spero Therapeutics, Inc. | -70.79 Million USD | -165.885% |
| Artelo Biosciences, Inc. | -6.82 Million USD | -2657.802% |
| 2seventy bio, Inc. | 181.71 Million USD | 203.58% |
| ADMA Biologics, Inc. | 90.06 Million USD | 308.98% |
| Clene Inc. | 3.34 Million USD | 5735.329% |
| Capricor Therapeutics, Inc. | -9.08 Million USD | -1972.291% |
| Boundless Bio, Inc. Common Stock | -21.51 Million USD | -774.994% |
| GeoVax Labs, Inc. | -6.45 Million USD | -2816.969% |
| Recursion Pharmaceuticals, Inc. | -344.12 Million USD | 45.305% |
| Citius Pharmaceuticals, Inc. | -25.99 Million USD | -623.932% |
| Contineum Therapeutics, Inc. Class A Common Stock | 177.66 Million USD | 205.94% |
| Relmada Therapeutics, Inc. | -4.09 Million USD | -4500.194% |
| Finch Therapeutics Group, Inc. | 5 Million USD | 3862.895% |
| ALX Oncology Holdings Inc. | -5.2 Million USD | -3513.361% |
| Vir Biotechnology, Inc. | -130.3 Million USD | -44.447% |
| Evaxion Biotech A/S | 5.28 Million USD | 3660.158% |
| Ocular Therapeutix, Inc. | -112.56 Million USD | -67.206% |
| Verve Therapeutics, Inc. | -131.27 Million USD | -43.381% |
| Trevena, Inc. | 2.25 Million USD | 8435.695% |
| Surrozen, Inc. | -32.66 Million USD | -476.231% |
| Tyra Biosciences, Inc. | -51.51 Million USD | -265.405% |
| Cingulate Inc. | 3.08 Million USD | 6205.72% |
| Galmed Pharmaceuticals Ltd. | -2.93 Million USD | -6308.58% |
| Unity Biotechnology, Inc. | 7.18 Million USD | 2718.895% |
| Tenax Therapeutics, Inc. | -9.29 Million USD | -1925.782% |
| Terns Pharmaceuticals, Inc. | -79.32 Million USD | -137.283% |
| ACADIA Pharmaceuticals Inc. | -131.45 Million USD | -43.185% |
| Connect Biopharma Holdings Limited | -105.54 Million USD | -78.337% |
| Clearmind Medicine Inc. | -3.94 Million USD | -4673.962% |
| Kronos Bio, Inc. | -36.05 Million USD | -422.05% |
| Bolt Biotherapeutics, Inc. | 9.4 Million USD | 2100.425% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 13008.341% |
| Viking Therapeutics, Inc. | -54.25 Million USD | -246.911% |
| Statera Biopharma, Inc. | 14.41 Million USD | 1405.596% |
| ImmunityBio, Inc. | 618.22 Million USD | 130.445% |
| Korro Bio, Inc. | -132.94 Million USD | -41.579% |
| Kineta, Inc. | -4.54 Million USD | -4044.902% |
| BioVie Inc. | -17.73 Million USD | -961.45% |
| Codexis, Inc. | -43.27 Million USD | -334.98% |
| Celularity Inc. | 65.19 Million USD | 388.725% |
| Crinetics Pharmaceuticals, Inc. | -3.16 Million USD | -5839.413% |
| Celcuity Inc. | 6.78 Million USD | 2874.67% |
| Virax Biolabs Group Limited | -3.36 Million USD | -5493.555% |
| Cibus, Inc. | -8.07 Million USD | -2230.032% |
| Eledon Pharmaceuticals, Inc. | -4.22 Million USD | -4350.698% |
| eFFECTOR Therapeutics, Inc. | 4.57 Million USD | 4218.6% |
| IN8bio, Inc. | -16.38 Million USD | -1048.453% |
| Kodiak Sciences Inc. | -103.87 Million USD | -81.199% |
| Annexon, Inc. | -193.75 Million USD | 2.857% |
| Adverum Biotechnologies, Inc. | 36 Thousand USD | 522933.333% |
| Assembly Biosciences, Inc. | -17.49 Million USD | -975.604% |
| Avalo Therapeutics, Inc. | -3.51 Million USD | -5257.814% |
| Ionis Pharmaceuticals, Inc. | 1.05 Billion USD | 117.853% |
| Eyenovia, Inc. | 1.25 Million USD | 15053.5% |
| Puma Biotechnology, Inc. | 26.9 Million USD | 799.573% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -5703.885% |
| Xilio Therapeutics, Inc. | -33.24 Million USD | -466.126% |
| Arcellx, Inc. | -296.95 Million USD | 36.617% |
| Cardiff Oncology, Inc. | -19.5 Million USD | -864.934% |
| Enanta Pharmaceuticals, Inc. | -58.87 Million USD | -219.694% |
| Regulus Therapeutics Inc. | -20.72 Million USD | -808.091% |
| Moolec Science SA | 117.61 Thousand USD | 160129.248% |
| Acumen Pharmaceuticals, Inc. | -38.39 Million USD | -390.169% |
| Geron Corporation | 14.76 Million USD | 1375.117% |
| LAVA Therapeutics N.V. | -37.91 Million USD | -396.387% |
| Royalty Pharma plc | 5.65 Billion USD | 103.326% |
| Atea Pharmaceuticals, Inc. | -141.42 Million USD | -33.092% |
| Greenwich LifeSciences, Inc. | -6.98 Million USD | -2592.926% |
| TFF Pharmaceuticals, Inc. | -5.36 Million USD | -3409.695% |
| Mersana Therapeutics, Inc. | -140.73 Million USD | -33.745% |
| Humacyte, Inc. | -22.48 Million USD | -737.054% |
| Structure Therapeutics Inc. | -124.33 Million USD | -51.376% |
| 89bio, Inc. | -289.05 Million USD | 34.884% |
| PMV Pharmaceuticals, Inc. | -25.24 Million USD | -645.662% |
| Avenue Therapeutics, Inc. | -1.78 Million USD | -10456.366% |
| Genelux Corporation | -6.89 Million USD | -2628.221% |
| Trevi Therapeutics, Inc. | -31.05 Million USD | -506.008% |
| Lexicon Pharmaceuticals, Inc. | 83.59 Million USD | 325.146% |
| Notable Labs, Ltd. | -9.77 Million USD | -1825.327% |
| Liquidia Corporation | -80.17 Million USD | -134.759% |
| Mustang Bio, Inc. | -3.73 Million USD | -4938.009% |
| Immunovant, Inc. | -635.22 Million USD | 70.37% |
| Quantum-Si incorporated | -118.55 Million USD | -58.759% |
| Arbutus Biopharma Corporation | -17.56 Million USD | -971.624% |
| DiaMedica Therapeutics Inc. | -4.14 Million USD | -4443.085% |
| Vera Therapeutics, Inc. | 8.02 Million USD | 2444.836% |
| Acasti Pharma Inc. | -23 Million USD | -718.17% |
| MiNK Therapeutics, Inc. | -3.36 Million USD | -5489.759% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -1058.322% |
| Xenon Pharmaceuticals Inc. | -137.74 Million USD | -36.649% |
| Elevai Labs, Inc. Common Stock | -3.11 Million USD | -5939.735% |
| NeuroBo Pharmaceuticals, Inc. | -22.23 Million USD | -746.617% |
| Tempest Therapeutics, Inc. | -18.56 Million USD | -913.625% |
| Soleno Therapeutics, Inc. | -169.27 Million USD | -11.19% |
| PepGen Inc. | -60.67 Million USD | -210.236% |
| Moleculin Biotech, Inc. | -22.97 Million USD | -719.203% |
| United Therapeutics Corporation | -507.7 Million USD | 62.927% |
| Nuvectis Pharma, Inc. | -19.12 Million USD | -884.105% |
| Solid Biosciences Inc. | -47.75 Million USD | -294.178% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -21733.013% |
| Immuneering Corporation | -54.94 Million USD | -242.574% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -4377.71% |
| Silo Pharma, Inc. | -3.52 Million USD | -5240.623% |
| Belite Bio, Inc | -87.27 Million USD | -115.673% |
| XOMA Corporation | -29 Million USD | -549.034% |
| ARS Pharmaceuticals, Inc. | -70.69 Million USD | -166.235% |
| Bionomics Limited | 227 Million USD | 182.913% |
| Apogee Therapeutics, Inc. | -116.28 Million USD | -61.865% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -7330.715% |
| uniQure N.V. | -102.95 Million USD | -82.825% |
| Cassava Sciences, Inc. | -121.13 Million USD | -55.379% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -4418.623% |
| Poseida Therapeutics, Inc. | 40.95 Million USD | 559.622% |
| Forte Biosciences, Inc. | -11.96 Million USD | -1473.614% |
| Anebulo Pharmaceuticals, Inc. | -3.09 Million USD | -5982.994% |
| Enlivex Therapeutics Ltd. | 106 Thousand USD | 177666.038% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -5703.885% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 2213.644% |
| FibroBiologics, Inc. Common Stock | -7.41 Million USD | -2438.026% |
| Altimmune, Inc. | -134.48 Million USD | -39.954% |
| Amicus Therapeutics, Inc. | 198.06 Million USD | 195.029% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -7330.715% |
| Compugen Ltd. | -12.9 Million USD | -1358.617% |
| Peak Bio, Inc. | 10.34 Million USD | 1920.282% |
| Zevra Therapeutics, Inc. | -283 Thousand USD | -66408.834% |
| Benitec Biopharma Inc. | -50.58 Million USD | -272.109% |
| Spyre Therapeutics, Inc. | -104.33 Million USD | -80.394% |
| NKGen Biotech, Inc. Common Stock | 19.64 Million USD | 1058.106% |
| Zura Bio Limited | -99.8 Million USD | -88.586% |
| PolyPid Ltd. | 6.17 Million USD | 3150.567% |
| Aileron Therapeutics, Inc. | 74.12 Million USD | 353.94% |
| NKGen Biotech, Inc. Warrants | 19.64 Million USD | 1058.106% |
| Instil Bio, Inc. | 75.35 Million USD | 349.768% |
| argenx SE | -2.02 Billion USD | 90.723% |
| Immunome, Inc. | -97.02 Million USD | -93.983% |
| Compass Therapeutics, Inc. | -22.49 Million USD | -736.719% |
| Verona Pharma plc | -220.44 Million USD | 14.617% |
| enGene Holdings Inc. Warrants | -71.74 Million USD | -162.353% |
| Shattuck Labs, Inc. | -121.42 Million USD | -55.011% |
| CervoMed Inc. | -7.79 Million USD | -2315.292% |
| LENZ Therapeutics, Inc. | -185.49 Million USD | -1.467% |
| Plus Therapeutics, Inc. | -4.37 Million USD | -4204.139% |
| Dianthus Therapeutics, Inc. | -131.73 Million USD | -42.872% |
| Moolec Science SA | 117.61 Thousand USD | 160129.248% |
| Enveric Biosciences, Inc. | -2.28 Million USD | -8126.481% |
| Inovio Pharmaceuticals, Inc. | 15.89 Million USD | 1283.894% |
| AnaptysBio, Inc. | -18.15 Million USD | -936.968% |
| Design Therapeutics, Inc. | -18.15 Million USD | -937.025% |
| Leap Therapeutics, Inc. | -70.38 Million USD | -167.43% |
| NeurAxis, Inc. | 145.7 Thousand USD | 129283.253% |
| Seelos Therapeutics, Inc. | 11.23 Million USD | 1775.748% |
| Lumos Pharma, Inc. | -28.49 Million USD | -560.583% |
| Achilles Therapeutics plc | -126.92 Million USD | -48.293% |
| enGene Holdings Inc. Common Stock | -71.74 Million USD | -162.353% |
| 180 Life Sciences Corp. | -655.73 Thousand USD | -28603.887% |
| Opiant Pharmaceuticals, Inc. | -20.77 Million USD | -806.044% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 13008.341% |
| Nutriband Inc. | -251.65 Thousand USD | -74692.277% |
| ORIC Pharmaceuticals, Inc. | -13.17 Million USD | -1329.049% |
| CG Oncology, Inc. Common stock | -7.44 Million USD | -2429.839% |
| Fractyl Health, Inc. Common Stock | 340.19 Million USD | 155.327% |
| Rani Therapeutics Holdings, Inc. | 23.73 Million USD | 893.006% |
| MoonLake Immunotherapeutics | -447.47 Million USD | 57.937% |
| Palisade Bio, Inc. | -12.06 Million USD | -1460.308% |
| Tourmaline Bio, Inc. | -140.31 Million USD | -34.145% |
| Beam Therapeutics Inc. | -262.72 Million USD | 28.358% |
| Neurogene Inc. | -131.95 Million USD | -42.64% |
| Mirum Pharmaceuticals, Inc. | 21.81 Million USD | 962.761% |
| AEON Biopharma, Inc. | -4.88 Million USD | -3756.967% |
| CARGO Therapeutics, Inc. Common Stock | -377.19 Million USD | 50.1% |
| Sesen Bio, Inc. | -112.55 Million USD | -67.228% |
| Enliven Therapeutics, Inc. | -99.86 Million USD | -88.484% |
| Kiora Pharmaceuticals, Inc. | -2.34 Million USD | -7916.891% |
| Iovance Biotherapeutics, Inc. | -39.02 Million USD | -382.294% |
| Taysha Gene Therapies, Inc. | -83.28 Million USD | -126.003% |
| Athira Pharma, Inc. | -88.99 Million USD | -111.486% |
| Vaccinex, Inc. | -1.28 Million USD | -14513.354% |
| HCW Biologics Inc. | 2.85 Million USD | 6688.777% |
| XOMA Corporation | -29 Million USD | -549.034% |
| Nektar Therapeutics | 210.24 Million USD | 189.526% |
| Arvinas, Inc. | -313.8 Million USD | 40.019% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 11697.829% |
| Merus N.V. | -192.88 Million USD | 2.418% |
| Omega Therapeutics, Inc. | 59.98 Million USD | 413.778% |
| Quince Therapeutics, Inc. | -6.93 Million USD | -2612.886% |
| Rezolute, Inc. | -68.16 Million USD | -176.112% |
| Clene Inc. | 3.34 Million USD | 5735.329% |
| Indaptus Therapeutics, Inc. | -13.18 Million USD | -1327.315% |
| BeyondSpring Inc. | -13.75 Million USD | -1268.375% |
| Synlogic, Inc. | -6.68 Million USD | -2715.557% |
| Allarity Therapeutics, Inc. | 1.13 Million USD | 16697.884% |
| Phio Pharmaceuticals Corp. | -8.45 Million USD | -2126.138% |
| Peak Bio, Inc. | 10.34 Million USD | 1920.282% |
| Werewolf Therapeutics, Inc. | -82.42 Million USD | -128.367% |
| Krystal Biotech, Inc. | -350.23 Million USD | 46.259% |
| Karyopharm Therapeutics Inc. | 124.12 Million USD | 251.637% |
| SpringWorks Therapeutics, Inc. | -168.99 Million USD | -11.375% |
| Lipella Pharmaceuticals Inc. | -3.15 Million USD | -5861.717% |
| MannKind Corporation | 143.89 Million USD | 230.8% |
| Ikena Oncology, Inc. | -109.15 Million USD | -72.432% |
| Cyclerion Therapeutics, Inc. | -7.57 Million USD | -2386.065% |
| Gyre Therapeutics, Inc. | -33.1 Million USD | -468.64% |
| Gossamer Bio, Inc. | 180.35 Million USD | 204.361% |
| CohBar, Inc. | -5.93 Million USD | -3073.639% |
| Cognition Therapeutics, Inc. | -29.74 Million USD | -532.715% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 4222.208% |
| Legend Biotech Corporation | -949.39 Million USD | 80.175% |
| Mural Oncology plc | -255.84 Million USD | 26.431% |
| Biora Therapeutics, Inc. | 32.21 Million USD | 684.262% |
| PaxMedica, Inc. Common Stock | -4.71 Million USD | -3895.634% |
| Disc Medicine, Inc. | -358.28 Million USD | 47.466% |
| Champions Oncology, Inc. | 4.81 Million USD | 4011.471% |
| REGENXBIO Inc. | 54.76 Million USD | 443.668% |
| Ensysce Biosciences, Inc. | -268.9 Thousand USD | -69894.459% |
| Anavex Life Sciences Corp. | -151.02 Million USD | -24.629% |
| Cellectar Biosciences, Inc. | -9.01 Million USD | -1988.547% |
| Edgewise Therapeutics, Inc. | -80.68 Million USD | -133.283% |
| Vaxart, Inc. | -8.24 Million USD | -2183.946% |
| PharmaCyte Biotech, Inc. | -50.17 Million USD | -275.09% |
| Aldeyra Therapeutics, Inc. | -127.16 Million USD | -48.012% |
| Cellectis S.A. | -43.85 Million USD | -329.187% |
| Longeveron Inc. | -2.9 Million USD | -6372.49% |
| Repare Therapeutics Inc. | -107.85 Million USD | -74.507% |
| Sarepta Therapeutics, Inc. | 968.37 Million USD | 119.437% |
| Inozyme Pharma, Inc. | 12 Million USD | 1667.977% |
| Revolution Medicines, Inc. | -608.2 Million USD | 69.053% |
| Nymox Pharmaceutical Corporation | -1.23 Million USD | -15202.439% |
| Third Harmonic Bio, Inc. | -265.11 Million USD | 29.005% |
| ArriVent BioPharma, Inc. Common Stock | -150.07 Million USD | -25.42% |
| AN2 Therapeutics, Inc. | -15.64 Million USD | -1102.914% |
| Anixa Biosciences, Inc. | -740 Thousand USD | -25335.135% |
| Vertex Pharmaceuticals Incorporated | -9.56 Billion USD | 98.032% |
| Denali Therapeutics Inc. | -74.86 Million USD | -151.413% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -1469.585% |
| Veru Inc. | 4.77 Million USD | 4037.682% |
| Corvus Pharmaceuticals, Inc. | -11.24 Million USD | -1573.662% |
| Cingulate Inc. | 3.08 Million USD | 6205.72% |
| Passage Bio, Inc. | 4.58 Million USD | 4205.125% |
| Context Therapeutics Inc. | -14.44 Million USD | -1202.576% |
| Exicure, Inc. | 5.84 Million USD | 3317.986% |
| Day One Biopharmaceuticals, Inc. | -230.37 Million USD | 18.299% |
| Oramed Pharmaceuticals Inc. | -39.57 Million USD | -375.663% |
| Scinai Immunotherapeutics Ltd. | 15.69 Million USD | 1299.541% |
| Rhythm Pharmaceuticals, Inc. | -58.82 Million USD | -219.988% |
| Nuvalent, Inc. | -335.38 Million USD | 43.88% |
| ABVC BioPharma, Inc. | 1.73 Million USD | 10952.537% |
| Carisma Therapeutics, Inc. | -74.48 Million USD | -152.705% |
| Unicycive Therapeutics, Inc. | -8.89 Million USD | -2017.21% |
| OmniAb, Inc. | 9.2 Million USD | 2145.203% |
| Anew Medical, Inc. | 1.43 Million USD | 13239.588% |
| Fennec Pharmaceuticals Inc. | 16.38 Million USD | 1248.961% |
| Lipocine Inc. | -4.75 Million USD | -3858.699% |
| Lexeo Therapeutics, Inc. Common Stock | -109.82 Million USD | -71.377% |
| Nautilus Biotechnology, Inc. | 15.23 Million USD | 1335.769% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -271.543% |
| G1 Therapeutics, Inc. | 24.89 Million USD | 856.147% |
| Bellerophon Therapeutics, Inc. | -6.72 Million USD | -2700.476% |
| Sage Therapeutics, Inc. | -65.82 Million USD | -185.931% |
| Ocugen, Inc. | -32.52 Million USD | -478.764% |
| Mind Medicine (MindMed) Inc. | -85.57 Million USD | -119.947% |
| Q32 Bio Inc. | -37.94 Million USD | -395.995% |
| Brainstorm Cell Therapeutics Inc. | -628 Thousand USD | -29871.338% |
| Alumis Inc. Common Stock | -13.52 Million USD | -1291.234% |
| Equillium, Inc. | -22.39 Million USD | -740.568% |
| Kyverna Therapeutics, Inc. | -25.56 Million USD | -636.155% |
| Coya Therapeutics, Inc. | -32.62 Million USD | -476.888% |
| CNS Pharmaceuticals, Inc. | -247.91 Thousand USD | -75821.183% |
| Galera Therapeutics, Inc. | 134.04 Million USD | 240.419% |
| Evelo Biosciences, Inc. | 3.19 Million USD | 5985.553% |
| Comera Life Sciences Holdings, Inc. | 328.44 Thousand USD | 57407.096% |
| Dominari Holdings Inc. | 195 Thousand USD | 96623.077% |
| Edesa Biotech, Inc. | -5.26 Million USD | -3473.632% |
| vTv Therapeutics Inc. | -8.91 Million USD | -2010.8% |
| Bio-Techne Corporation | 267.74 Million USD | 170.298% |
| Agios Pharmaceuticals, Inc. | -16.2 Million USD | -1061.207% |
| Harmony Biosciences Holdings, Inc. | -118.09 Million USD | -59.382% |
| Prelude Therapeutics Incorporated | -8.4 Million USD | -2139.914% |
| Candel Therapeutics, Inc. | -12.65 Million USD | -1387.788% |
| iTeos Therapeutics, Inc. | -245.11 Million USD | 23.213% |
| Nkarta, Inc. | 57.29 Million USD | 428.487% |
| BioCardia, Inc. | 212 Thousand USD | 88883.019% |
| Iterum Therapeutics plc | 13.43 Million USD | 1500.655% |